I G 225 (Gemfibrozil 600 mg)

Pill with imprint I G 225 is White, Elliptical/Oval and has been identified as Gemfibrozil 600 mg. It is supplied by Cipla USA, Inc.

Gemfibrozil is used in the treatment of hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia; high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for I G 225

Gemfibrozil

Imprint: I G 225
Strength: 600 mg
Color: White
Size: 19.00 mm
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Cipla USA, Inc.
Manufacturer: InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC): 69097-0821
Inactive Ingredients: silicon dioxide, croscarmellose sodium, calcium stearate, microcrystalline cellulose, methylcellulose (15 mPa.s), hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80
Note: Inactive ingredients may vary.